AP Biosciences Statistics

Total Valuation

AP Biosciences has a market cap or net worth of TWD 16.69 billion. The enterprise value is 15.58 billion.

Market Cap	16.69B
Enterprise Value	15.58B

Important Dates

The next estimated earnings date is Tuesday, May 12, 2026.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

AP Biosciences has 85.57 million shares outstanding. The number of shares has increased by 13.06% in one year.

Current Share Class	85.57M
Shares Outstanding	85.57M
Shares Change (YoY)	+13.06%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	5.87%
Owned by Institutions (%)	5.26%
Float	42.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	13.13
P/TBV Ratio	13.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-35.02
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-41.30

Financial Position

The company has a current ratio of 29.94, with a Debt / Equity ratio of 0.05.

Current Ratio	29.94
Quick Ratio	29.73
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-0.16
Interest Coverage	-320.49

Financial Efficiency

Return on equity (ROE) is -30.74% and return on invested capital (ROIC) is -18.86%.

Return on Equity (ROE)	-30.74%
Return on Assets (ROA)	-18.45%
Return on Invested Capital (ROIC)	-18.86%
Return on Capital Employed (ROCE)	-34.46%
Weighted Average Cost of Capital (WACC)	4.21%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +366.27% in the last 52 weeks. The beta is -0.01, so AP Biosciences's price volatility has been lower than the market average.

Beta (5Y)	-0.01
52-Week Price Change	+366.27%
50-Day Moving Average	183.60
200-Day Moving Average	134.56
Relative Strength Index (RSI)	50.59
Average Volume (20 Days)	765,205

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-456.38M
Pretax Income	-444.77M
Net Income	-444.77M
EBITDA	-443.10M
EBIT	-456.38M
Earnings Per Share (EPS)	-5.23

Full Income Statement

Balance Sheet

The company has 1.17 billion in cash and 59.51 million in debt, with a net cash position of 1.11 billion or 12.99 per share.

Cash & Cash Equivalents	1.17B
Total Debt	59.51M
Net Cash	1.11B
Net Cash Per Share	12.99
Equity (Book Value)	1.27B
Book Value Per Share	14.85
Working Capital	1.18B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -352.09 million and capital expenditures -25.03 million, giving a free cash flow of -377.12 million.

Operating Cash Flow	-352.09M
Capital Expenditures	-25.03M
Depreciation & Amortization	13.28M
Net Borrowing	-11.40M
Free Cash Flow	-377.12M
FCF Per Share	-4.41

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AP Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.06%
Shareholder Yield	-13.06%
Earnings Yield	-2.67%
FCF Yield	-2.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1